Literature DB >> 11023824

Characterization of the human liver fructose-1,6-bisphosphatase gene promoter.

B Herzog1, M Waltner-Law, D K Scott, K Eschrich, D K Granner.   

Abstract

Fructose-1,6-bisphosphatase (FBPase; EC 3.1.3.11), an important gluconeogenic enzyme, catalyses the hydrolysis of fructose 1, 6-bisphosphate to fructose 6-phosphate and P(i). Enzyme activity is mainly regulated by the allosteric inhibitors fructose 2, 6-bisphosphate and AMP. Although some observations about hormonal regulation of the enzyme have been published, the FBPase promoter has not been studied in detail. Here we report an in vitro characterization of the FBPase promoter with respect to the elements that are required for basal promoter activity. Transient transfection of H4IIE rat hepatoma cells, combined with site-directed mutagenesis, demonstrated that an enhancer box, three GC-boxes and a nuclear factor kappaB (NF-kappaB)-binding element are important for hepatic FBPase promoter activity. These elements are found in the region located between -405 to +25 bp relative to the transcription start site. Electrophoretic-mobility-shift assays and supershift analysis confirmed that upstream stimulatory factor 1 (USF1)/USF2, specificity protein 1 (Sp1)/Sp3 and NF-kappaB respectively bind to these sites. The present study provides the basis for a more comprehensive screening for mutations in FBPase-deficient patients and for further studies of the transcriptional regulation of this gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023824      PMCID: PMC1221374     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver.

Authors:  M Casado; V S Vallet; A Kahn; S Vaulont
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

2.  Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose.

Authors:  V S Vallet; M Casado; A A Henrion; D Bucchini; M Raymondjean; A Kahn; S Vaulont
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

3.  Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene.

Authors:  P B Iynedjian
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

4.  Studying the recruitment of Sp1 to the beta-globin promoter with an in vivo method: protein position identification with nuclease tail (PIN*POINT).

Authors:  J S Lee; C H Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Involvement of HNF-1 in the regulation of phosphoenolpyruvate carboxykinase gene expression in the kidney.

Authors:  H Cassuto; Y Olswang; A F Livoff; H Nechushtan; R W Hanson; L Reshef
Journal:  FEBS Lett       Date:  1997-08-04       Impact factor: 4.124

6.  Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice.

Authors:  M Sirito; Q Lin; J M Deng; R R Behringer; M Sawadogo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 7.  A survey of 178 NF-Y binding CCAAT boxes.

Authors:  R Mantovani
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

8.  Human fructose-1,6-bisphosphatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2-q22.3, and mutation screening in subjects with fructose-1,6-bisphosphatase deficiency.

Authors:  M R el-Maghrabi; A J Lange; W Jiang; K Yamagata; M Stoffel; J Takeda; A A Fernald; M M Le Beau; G I Bell; L Baker
Journal:  Genomics       Date:  1995-06-10       Impact factor: 5.736

9.  The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.

Authors:  B Lin; D W Morris; J Y Chou
Journal:  Biochemistry       Date:  1997-11-18       Impact factor: 3.162

10.  Isolation and characterization of an allelic cDNA for human muscle fructose-1,6-bisphosphatase.

Authors:  H Tillmann; K Eschrich
Journal:  Gene       Date:  1998-06-08       Impact factor: 3.688

View more
  6 in total

1.  Proteomic analysis of fructose-induced fatty liver in hamsters.

Authors:  Lihe Zhang; German Perdomo; Dae Hyun Kim; Shen Qu; Steven Ringquist; Massimo Trucco; H Henry Dong
Journal:  Metabolism       Date:  2008-08       Impact factor: 8.694

2.  Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question.

Authors:  Khalid O Alfarouk; Daniel Verduzco; Cyril Rauch; Abdel Khalig Muddathir; H H Bashir Adil; Gamal O Elhassan; Muntaser E Ibrahim; Julian David Polo Orozco; Rosa Angela Cardone; Stephan J Reshkin; Salvador Harguindey
Journal:  Oncoscience       Date:  2014-12-18

3.  CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.

Authors:  Siriluck Wattanavanitchakorn; Pinnara Rojvirat; Tanit Chavalit; Michael J MacDonald; Sarawut Jitrapakdee
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

Review 4.  Targeting FBPase is an emerging novel approach for cancer therapy.

Authors:  Gao-Min Liu; Yao-Ming Zhang
Journal:  Cancer Cell Int       Date:  2018-03-09       Impact factor: 5.722

5.  Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation.

Authors:  Dongning Pan; Chunxiao Mao; Yong-Xu Wang
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

6.  Predicting combinatorial binding of transcription factors to regulatory elements in the human genome by association rule mining.

Authors:  Xochitl C Morgan; Shulin Ni; Daniel P Miranker; Vishwanath R Iyer
Journal:  BMC Bioinformatics       Date:  2007-11-15       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.